The dose-response effects of uric acid on the prevalence of metabolic syndrome and electrocardiographic left ventricular hypertrophy in healthy individuals

被引:29
作者
Liu, C. -W. [1 ,2 ,3 ]
Chen, K. -H. [3 ,4 ]
Tseng, C. -K. [1 ]
Chang, W. -C. [1 ]
Wu, Y. -W. [3 ,5 ,6 ,7 ,8 ]
Hwang, J. -J. [3 ,5 ,9 ]
机构
[1] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Songshan Branch, Taipei 10581, Taiwan
[2] Far Eastern Mem Hosp, Cardiol Div, Cardiovasc Med Ctr, New Taipei 22060, Taiwan
[3] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10051, Taiwan
[4] Tri Serv Gen Hosp, Dept Clin Pathol, Songshan Branch, Natl Def Med Ctr, Taipei 10581, Taiwan
[5] Natl Taiwan Univ, Dept Internal Med, Coll Med & Hosp, Taipei 10581, Taiwan
[6] Natl Taiwan Univ, Dept Nucl Med, Coll Med & Hosp, Taipei 10581, Taiwan
[7] Far Eastern Mem Hosp, Div Cardiovasc, Dept Nucl Med & Cardiol, Med Ctr, New Taipei 22060, Taiwan
[8] Natl Yang Ming Univ, Sch Med, Taipei 11221, Taiwan
[9] Natl Taiwan Univ Hosp, Yunlin Branch, Dept Internal Med, Taipei 64057, Yunlin, Taiwan
关键词
Uric acid; Metabolic syndrome; Left ventricular hypertrophy; Cardiovascular disease; Urate-lowering therapy; OXIDATIVE STRESS; MORTALITY; HYPERURICEMIA; ASSOCIATION; PREDICTOR; DISEASE; RISK;
D O I
10.1016/j.numecd.2018.10.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim: Hyperuricemia (HUA) is associated with the prevalence of metabolic syndrome (MetS) and cardiovascular risks in various populations. HUA is also able to induce cardiomyocyte hypertrophy in mouse models. However, the dose-response effects of serum uric acid (SUA) on the prevalence of MetS and electrocardiographic left ventricular hypertrophy (LVH) are unclear. Methods and results: We retrospectively collected data from 18,932 individuals who underwent an annual health examination between 1/1/2016 and 12/31/2016. We excluded those with systemic diseases or missing questionnaires. The primary study endpoints were the prevalence of MetS and LVH, which were defined by the criteria for the Taiwanese population and the "SPRINT" trial. The cohort consisted of 17,913 individuals with a mean age of 31.2 years (SD 7.4) and a mean body mass index of 24.6 kg/m(2) (SD 3.6); 87.1% of the individuals were men. The prevalence rates of HUA, MetS, and LVH were 29.5%, 9.4%, and 0.32%, respectively, in the overall study population. The HUA group was predominantly male and had significantly poorer lifestyle choices and greater laboratory cardiometabolic biomarker values than did the normouricemic group. However, the frequencies of physical activity were comparable between the two groups. After adjusting for confounders, SUA was associated with MetS (OR:1.473, 95% CI:1.408-1.540, P < 0.001) and LVH (OR:1.301, 95% CI:1.064-1.591, P = 0.01). Conclusion: We demonstrated that the dose-response effects of SUA are associated with the prevalence of MetS and electrocardiographic LVH in healthy individuals from Taiwan. Based on this evidence, future studies should investigate urate-lowering therapy and cardiovascular benefits in individuals with HUA (C) 2018 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:30 / 38
页数:9
相关论文
共 32 条
[1]   Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials [J].
Bredemeier, Markus ;
Lopes, Lediane Moreira ;
Eisenreich, Matheus Augusto ;
Hickmann, Sheila ;
Bongiorno, Guilherme Kopik ;
d'Avila, Rui ;
Bittencourt Morsch, Andre Luis ;
Stein, Fernando da Silva ;
Dias Campos, Guilherme Gomes .
BMC CARDIOVASCULAR DISORDERS, 2018, 18
[2]   Uricaemia and left ventricular mass in hypertensive patients [J].
Catena, Cristiana ;
Colussi, GianLuca ;
Capobianco, Frine ;
Brosolo, Gabriele ;
Sethi, Leonardo A. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 (10) :972-981
[3]   Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study [J].
Chen, Jiunn-Horng ;
Lan, Joung-Liang ;
Cheng, Chi-Fung ;
Liang, Wen-Miin ;
Lin, Hsiao-Yi ;
Tsay, Gregory J. ;
Yeh, Wen-Ting ;
Pan, Wen-Harn .
PLOS ONE, 2015, 10 (12)
[4]   Relationship Between Serum Uric Acid and Electrocardiographic Alterations in a Large Sample of General Population: Data From the Brisighella Heart Study [J].
Cicero A.F.G. ;
Rosticci M. ;
Reggi A. ;
Derosa G. ;
Parini A. ;
Grandi E. ;
D’Addato S. ;
Borghi C. .
High Blood Pressure & Cardiovascular Prevention, 2015, 22 (2) :129-134
[5]   Serum uric acid and other short-term predictors of electrocardiographic alterations in the Brisighella Heart Study cohort [J].
Cicero, Arrigo F. G. ;
Rosticci, Martina ;
Tocci, Giuliano ;
Bacchelli, Stefano ;
Urso, Riccado ;
D'Addato, Sergio ;
Borghi, Claudio .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2015, 26 (04) :255-258
[6]   Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system [J].
Corry, Dalila B. ;
Eslami, Pirooz ;
Yamamoto, Kei ;
Nyby, Michael D. ;
Makino, Hirofumi ;
Tuck, Michael L. .
JOURNAL OF HYPERTENSION, 2008, 26 (02) :269-275
[7]   Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population [J].
Cuspidi, Cesare ;
Facchetti, Rita ;
Bombelli, Michele ;
Sala, Carla ;
Tadic, Marijana ;
Grassi, Guido ;
Mancia, Giuseppe .
AMERICAN JOURNAL OF HYPERTENSION, 2017, 30 (03) :279-285
[8]   Uric acid and cardiovascular risk [J].
Feig, Daniel I. ;
Kang, Duk-Hee ;
Johnson, Richard J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17) :1811-1821
[9]   Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk [J].
Grassi, Davide ;
Ferri, Livia ;
Desideri, Giovambattista ;
Di Giosia, Paolo ;
Cheli, Paola ;
Del Pinto, Rita ;
Properzi, Giuliana ;
Ferri, Claudio .
CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (13) :2432-2438
[10]   Prevalence of obesity and metabolic syndrome in Taiwan [J].
Hwang, Lee-Ching ;
Bai, Chyi-Huey ;
Chen, Chien-Jen .
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2006, 105 (08) :626-635